ロード中...
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder characterized by motor as well as nonmotor symptoms for which there is currently no cure. The Q175 mouse model of HD recapitulates many of the symptoms identified in HD patients including disruptions of the sleep/wak...
保存先:
| 出版年: | Pharmacol Res Perspect |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625154/ https://ncbi.nlm.nih.gov/pubmed/28971617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.344 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|